Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
169.59
+1.63 (0.97%)
Apr 3, 2025, 1:44 PM EDT - Market open
Quest Diagnostics Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$179.57
Upside
+5.88%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Redburn Atlantic | Redburn Atlantic | Strong Buy Initiates $195 | Strong Buy | Initiates | $195 | +14.98% | Apr 2, 2025 |
| Baird | Baird | Buy Maintains $190 → $191 | Buy | Maintains | $190 → $191 | +12.62% | Mar 20, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $185 | Strong Buy → Hold | Downgrades | $185 | +9.09% | Mar 4, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $173 → $180 | Hold | Maintains | $173 → $180 | +6.14% | Feb 4, 2025 |
| Mizuho | Mizuho | Buy Maintains $177 → $178 | Buy | Maintains | $177 → $178 | +4.96% | Feb 3, 2025 |
| UBS | UBS | Hold Maintains $166 → $170 | Hold | Maintains | $166 → $170 | +0.24% | Feb 3, 2025 |
| Piper Sandler | Piper Sandler | Hold Reiterates $165 → $180 | Hold | Reiterates | $165 → $180 | +6.14% | Feb 3, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $172 → $182 | Hold | Maintains | $172 → $182 | +7.32% | Jan 31, 2025 |
| Barclays | Barclays | Hold Maintains $168 → $175 | Hold | Maintains | $168 → $175 | +3.19% | Jan 31, 2025 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $135 → $174 | Hold → Buy | Upgrades | $135 → $174 | +2.60% | Jan 6, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $145 → $172 | Hold → Buy | Upgrades | $145 → $172 | +1.42% | Dec 17, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $179 → $182 | Strong Buy | Maintains | $179 → $182 | +7.32% | Dec 13, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $185 | Strong Buy | Initiates | $185 | +9.09% | Dec 10, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $150 → $165 | Hold | Maintains | $150 → $165 | -2.71% | Oct 28, 2024 |
| Mizuho | Mizuho | Buy Maintains $160 → $174 | Buy | Maintains | $160 → $174 | +2.60% | Oct 24, 2024 |
| UBS | UBS | Hold Maintains $165 → $166 | Hold | Maintains | $165 → $166 | -2.12% | Oct 23, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.